|
2020-02-20 |
2020-02-20 |
B
Purchase
|
Bald Eagle Acquisition Corp
Large shareholder
|
40,926,025
+100.0%
18.75
USD 767,362,969
|
40,926,025
+100.0%
|
18.75
|
USD 767,362,969
|
|
|
2019-12-26 |
2019-12-24 |
PS
Planned sale
|
Fust Matthew K
|
3,000
-37.3%
15.00
USD 45,000
|
3,000
-37.3%
|
15.00
|
USD 45,000
|
|
|
2019-12-13 |
2019-12-12 |
PS
Planned sale
|
Fust Matthew K
|
3,000
-27.1%
12.00
USD 36,000
|
3,000
-27.1%
|
12.00
|
USD 36,000
|
|
|
2019-09-16 |
2019-09-12 |
S
Sale
|
Fust Matthew K
|
6,000
-35.2%
8.77
USD 52,636
|
6,000
-35.2%
|
8.77
|
USD 52,636
|
|
|
2019-08-19 |
2019-08-19 |
B
Purchase
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
23,419
+44.6%
8.54
USD 199,998
|
23,419
+44.6%
|
8.54
|
USD 199,998
|
|
|
2019-08-19 |
2019-08-19 |
S
Sale
|
Pena Luis C.
Chief Development Officer
|
23,419
-57.6%
8.54
USD 199,998
|
23,419
-57.6%
|
8.54
|
USD 199,998
|
|
|
2019-04-09 |
2019-04-08 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
35,000
-79.7%
15.00
USD 525,000
|
35,000
-79.7%
|
15.00
|
USD 525,000
|
|
|
2018-10-19 |
2018-10-19 |
PS
Planned sale
|
Fust Matthew K
|
4,000
-22.2%
13.75
USD 55,000
|
4,000
-22.2%
|
13.75
|
USD 55,000
|
|
|
2018-07-09 |
2018-07-09 |
PP
Planned purchase
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
12,000
+17.8%
10.00
USD 119,951
|
12,000
+17.8%
|
10.00
|
USD 119,951
|
|
|
2018-07-02 |
2018-07-02 |
PP
Planned purchase
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
13,780
+25.6%
8.71
USD 119,998
|
13,780
+25.6%
|
8.71
|
USD 119,998
|
|
|
2018-06-25 |
2018-06-25 |
PP
Planned purchase
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
12,150
+29.2%
9.84
USD 119,586
|
12,150
+29.2%
|
9.84
|
USD 119,586
|
|
|
2018-06-18 |
2018-06-18 |
PP
Planned purchase
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
11,875
+40.0%
10.10
USD 119,954
|
11,875
+40.0%
|
10.10
|
USD 119,954
|
|
|
2018-03-06 |
2018-03-02 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
2,500
-47.2%
25.00
USD 62,500
|
2,500
-47.2%
|
25.00
|
USD 62,500
|
|
|
2018-03-02 |
2018-03-01 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
500
-15.1%
25.32
USD 12,658
|
500
-15.1%
|
25.32
|
USD 12,658
|
|
|
2018-03-02 |
2018-03-01 |
PS
Planned sale
|
Cohen David E
|
600
-2.0%
25.85
USD 15,510
|
600
-2.0%
|
25.85
|
USD 15,510
|
|
|
2018-02-02 |
2018-02-01 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
3,000
-51.7%
28.55
USD 85,642
|
3,000
-51.7%
|
28.55
|
USD 85,642
|
|
|
2018-02-02 |
2018-02-01 |
PS
Planned sale
|
Cohen David E
|
600
-1.9%
28.87
USD 17,322
|
600
-1.9%
|
28.87
|
USD 17,322
|
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
100
-3.4%
28.03
USD 2,803
|
100
-3.4%
|
28.03
|
USD 2,803
|
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
2,900
-50.0%
27.04
USD 78,407
|
2,900
-50.0%
|
27.04
|
USD 78,407
|
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
Cohen David E
|
600
-1.9%
28.03
USD 16,818
|
600
-1.9%
|
28.03
|
USD 16,818
|
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
Griffith Christopher M.
SVP Head Corp. Dev. & Strategy
|
200
-0.5%
27.91
USD 5,581
|
200
-0.5%
|
27.91
|
USD 5,581
|
|
|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
Griffith Christopher M.
SVP Head Corp. Dev. & Strategy
|
18,258
-29.6%
27.04
USD 493,773
|
18,258
-29.6%
|
27.04
|
USD 493,773
|
|
|
2017-12-20 |
2017-12-18 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
3,000
-43.9%
27.34
USD 82,011
|
3,000
-43.9%
|
27.34
|
USD 82,011
|
|
|
2017-12-15 |
2017-12-13 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
5,000
-26.8%
27.51
USD 137,566
|
5,000
-26.8%
|
27.51
|
USD 137,566
|
|
|
2017-12-05 |
2017-12-01 |
PS
Planned sale
|
Cohen David E
|
600
-1.9%
25.49
USD 15,294
|
600
-1.9%
|
25.49
|
USD 15,294
|
|
|
2017-11-03 |
2017-11-02 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
5,000
-27.1%
27.52
USD 137,608
|
5,000
-27.1%
|
27.52
|
USD 137,608
|
|
|
2017-11-03 |
2017-11-01 |
PS
Planned sale
|
Cohen David E
|
600
-1.8%
26.82
USD 16,092
|
600
-1.8%
|
26.82
|
USD 16,092
|
|
|
2017-10-13 |
2017-10-11 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
7,500
-21.8%
30.04
USD 225,300
|
7,500
-21.8%
|
30.04
|
USD 225,300
|
|
|
2017-10-11 |
2017-10-10 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
5,000
-27.1%
27.52
USD 137,606
|
5,000
-27.1%
|
27.52
|
USD 137,606
|
|
|
2017-10-03 |
2017-10-02 |
PS
Planned sale
|
Cohen David E
|
600
-1.8%
26.99
USD 16,194
|
600
-1.8%
|
26.99
|
USD 16,194
|
|
|
2017-09-19 |
2017-09-18 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
9,500
-41.4%
27.51
USD 261,336
|
9,500
-41.4%
|
27.51
|
USD 261,336
|
|
|
2017-09-05 |
2017-09-01 |
PS
Planned sale
|
Cohen David E
|
600
-1.8%
23.56
USD 14,136
|
600
-1.8%
|
23.56
|
USD 14,136
|
|
|
2017-08-29 |
2017-08-28 |
PS
Planned sale
|
Cohen David E
|
600
-1.7%
23.81
USD 14,286
|
600
-1.7%
|
23.81
|
USD 14,286
|
|
|
2017-08-14 |
2017-08-14 |
B
Purchase
|
CRAVES FRED B
|
10,000
+50.0%
23.95
USD 239,460
|
10,000
+50.0%
|
23.95
|
USD 239,460
|
|
|
2017-08-14 |
2017-08-10 |
B
Purchase
|
CRAVES FRED B
|
20,000
+inf%
22.57
USD 451,470
|
20,000
+inf%
|
22.57
|
USD 451,470
|
|
|
2017-08-02 |
2017-08-01 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
500
-6.1%
27.58
USD 13,791
|
500
-6.1%
|
27.58
|
USD 13,791
|
|
|
2017-07-06 |
2017-07-05 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
2,500
-6.8%
30.00
USD 75,008
|
2,500
-6.8%
|
30.00
|
USD 75,008
|
|
|
2017-07-05 |
2017-07-03 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
5,000
-39.4%
29.06
USD 145,298
|
5,000
-39.4%
|
29.06
|
USD 145,298
|
|
|
2017-06-21 |
2017-06-20 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
2,500
-6.3%
30.01
USD 75,032
|
2,500
-6.3%
|
30.01
|
USD 75,032
|
|
|
2017-06-05 |
2017-06-02 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
1,121
-12.7%
27.61
USD 30,951
|
1,121
-12.7%
|
27.61
|
USD 30,951
|
|
|
2017-06-05 |
2017-06-01 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
3,879
-33.5%
27.50
USD 106,673
|
3,879
-33.5%
|
27.50
|
USD 106,673
|
|
|
2017-05-16 |
2017-05-15 |
PS
Planned sale
|
Griffith Christopher M.
SVP Head Corp. Dev. & Strategy
|
1,312
-2.8%
27.07
USD 35,516
|
1,312
-2.8%
|
27.07
|
USD 35,516
|
|
|
2017-05-03 |
2017-05-01 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
2,500
-6.0%
33.65
USD 84,116
|
2,500
-6.0%
|
33.65
|
USD 84,116
|
|
|
2017-05-03 |
2017-05-01 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
100
-1.5%
34.39
USD 3,439
|
100
-1.5%
|
34.39
|
USD 3,439
|
|
|
2017-05-03 |
2017-05-01 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
7,900
-54.6%
33.65
USD 265,833
|
7,900
-54.6%
|
33.65
|
USD 265,833
|
|
|
2017-05-03 |
2017-05-01 |
PS
Planned sale
|
RINGO WILLIAM R
|
500
-100.0%
34.06
USD 17,030
|
500
-100.0%
|
34.06
|
USD 17,030
|
|
|
2017-04-18 |
2017-04-17 |
PS
Planned sale
|
Griffith Christopher M.
SVP Head Corp. Dev. & Strategy
|
1,303
-2.8%
33.97
USD 44,267
|
1,303
-2.8%
|
33.97
|
USD 44,267
|
|
|
2017-04-04 |
2017-04-03 |
PS
Planned sale
|
RINGO WILLIAM R
|
500
-100.0%
34.03
USD 17,015
|
500
-100.0%
|
34.03
|
USD 17,015
|
|
|
2017-04-04 |
2017-04-03 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
1,414
-17.9%
34.03
USD 48,118
|
1,414
-17.9%
|
34.03
|
USD 48,118
|
|
|
2017-04-04 |
2017-04-03 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
6,586
-45.5%
33.38
USD 219,831
|
6,586
-45.5%
|
33.38
|
USD 219,831
|
|
|
2017-04-04 |
2017-04-03 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
521
-1.2%
34.03
USD 17,730
|
521
-1.2%
|
34.03
|
USD 17,730
|
|
|
2017-04-04 |
2017-04-03 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
1,979
-4.4%
33.40
USD 66,106
|
1,979
-4.4%
|
33.40
|
USD 66,106
|
|
|
2017-03-16 |
2017-03-15 |
PS
Planned sale
|
Griffith Christopher M.
SVP Head Corp. Dev. & Strategy
|
100
-0.2%
36.37
USD 3,637
|
100
-0.2%
|
36.37
|
USD 3,637
|
|
|
2017-03-16 |
2017-03-15 |
PS
Planned sale
|
Griffith Christopher M.
SVP Head Corp. Dev. & Strategy
|
1,203
-2.6%
35.74
USD 42,993
|
1,203
-2.6%
|
35.74
|
USD 42,993
|
|
|
2017-03-07 |
2017-03-03 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
4,000
-38.2%
37.60
USD 150,416
|
4,000
-38.2%
|
37.60
|
USD 150,416
|
|
|
2017-03-02 |
2017-03-01 |
PS
Planned sale
|
RINGO WILLIAM R
|
500
-100.0%
35.09
USD 17,547
|
500
-100.0%
|
35.09
|
USD 17,547
|
|
|
2017-03-02 |
2017-03-01 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
100
-0.2%
35.89
USD 3,589
|
100
-0.2%
|
35.89
|
USD 3,589
|
|
|
2017-03-02 |
2017-03-01 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
400
-0.9%
34.49
USD 13,795
|
400
-0.9%
|
34.49
|
USD 13,795
|
|
|
2017-03-02 |
2017-03-01 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
1,200
-2.6%
33.81
USD 40,569
|
1,200
-2.6%
|
33.81
|
USD 40,569
|
|
|
2017-03-02 |
2017-03-01 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
800
-1.7%
32.60
USD 26,079
|
800
-1.7%
|
32.60
|
USD 26,079
|
|
|
2017-03-02 |
2017-03-01 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
272
-4.0%
35.91
USD 9,769
|
272
-4.0%
|
35.91
|
USD 9,769
|
|
|
2017-03-02 |
2017-03-01 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
600
-8.2%
35.08
USD 21,047
|
600
-8.2%
|
35.08
|
USD 21,047
|
|
|
2017-03-02 |
2017-03-01 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
4,328
-37.1%
33.91
USD 146,782
|
4,328
-37.1%
|
33.91
|
USD 146,782
|
|
|
2017-03-02 |
2017-03-01 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
5,800
-33.2%
32.99
USD 191,347
|
5,800
-33.2%
|
32.99
|
USD 191,347
|
|
|
2017-02-16 |
2017-02-15 |
PS
Planned sale
|
Griffith Christopher M.
SVP Head Corp. Dev. & Strategy
|
403
-0.9%
31.38
USD 12,646
|
403
-0.9%
|
31.38
|
USD 12,646
|
|
|
2017-02-16 |
2017-02-15 |
PS
Planned sale
|
Griffith Christopher M.
SVP Head Corp. Dev. & Strategy
|
900
-1.9%
30.52
USD 27,472
|
900
-1.9%
|
30.52
|
USD 27,472
|
|
|
2017-02-16 |
2017-02-15 |
PS
Planned sale
|
RINGO WILLIAM R
|
500
-100.0%
32.00
USD 16,000
|
500
-100.0%
|
32.00
|
USD 16,000
|
|
|
2017-02-15 |
2017-02-14 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
1,505
-3.1%
30.00
USD 45,153
|
1,505
-3.1%
|
30.00
|
USD 45,153
|
|
|
2017-02-03 |
2017-02-01 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
204
-3.1%
29.99
USD 6,118
|
204
-3.1%
|
29.99
|
USD 6,118
|
|
|
2017-02-03 |
2017-02-01 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
4,796
-41.8%
29.33
USD 140,647
|
4,796
-41.8%
|
29.33
|
USD 140,647
|
|
|
2017-02-02 |
2017-02-01 |
PS
Planned sale
|
BAUER EUGENE A
Chief Medical Officer
|
995
-2.0%
30.00
USD 29,852
|
995
-2.0%
|
30.00
|
USD 29,852
|
|
|
2017-01-19 |
2017-01-17 |
PS
Planned sale
|
Griffith Christopher M.
VP Corp. Dev. & Strategy
|
200
-0.4%
30.08
USD 6,016
|
200
-0.4%
|
30.08
|
USD 6,016
|
|
|
2017-01-19 |
2017-01-17 |
PS
Planned sale
|
Griffith Christopher M.
VP Corp. Dev. & Strategy
|
1,103
-2.4%
28.94
USD 31,921
|
1,103
-2.4%
|
28.94
|
USD 31,921
|
|
|
2017-01-05 |
2017-01-04 |
PS
Planned sale
|
WIGGANS THOMAS G
CEO & Chairman of the Board
|
3,000
-31.7%
32.51
USD 97,543
|
3,000
-31.7%
|
32.51
|
USD 97,543
|
|
|
2017-01-04 |
2017-01-04 |
PS
Planned sale
|
RINGO WILLIAM R
|
500
-100.0%
32.00
USD 16,000
|
500
-100.0%
|
32.00
|
USD 16,000
|
|
